Clinical trials
Phase 2/3 Hematologic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2015 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
| Completed | 6 |
| Terminated | 3 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Research UK | 7 |
| Nanfang Hospital, Southern Medical University | 3 |
| Azienda Ospedaliera San Giovanni Battista | 1 |
| Beijing InnoCare Pharma Tech Co., Ltd. | 1 |
| Emory University | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Gamida Cell -Teva Joint Venture Ltd. | 1 |
| Hospital Israelita Albert Einstein | 1 |
| Kiadis Pharma | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 24 |
| Neoplasms | 8 |
| Neoplasms by Histologic Type | 6 |
| Neoplasms by Site | 6 |
| Glioma | 4 |
| Lymphoproliferative Disorders | 4 |
| Colorectal Neoplasms | 3 |
| Graft vs Host Disease | 3 |
| Lymphoma | 3 |
| Multiple Myeloma | 3 |
Trials
Showing 76 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.